Center for Health and Biosciences Thu, Dec. 05 - Fri, Dec. 06, 2024 | 8 am - 5 pm 2024 Annual Texas NMDOH Consortium Conference: Advancing Research, Policy, and Practice See Details
Center for the U.S. and Mexico | Mexico Forum Thu, Dec. 05, 2024 | 8:30 am - 6 pm Mexico Country Outlook 2025 See Details
Presidential Elections Mon, Dec. 09, 2024 | 8:30 am - 4:30 pm The New Playbook: Lessons from the 2024 Election See Details
U.S. Health System Transformation | Center for Health and Biosciences | Newsletter Health Policy Research Newsletter -- March 2014 March 3, 2014 | Hagop M. Kantarjian toggle sidebar Toggle Sidebar Table of Contents Author(s) Hagop M. Kantarjian Nonresident Fellow in Health Policy Share this Publication Facebook Twitter Email Linkedin Print This Publication Exorbitant prices for cancer drugs harm patients who cannot afford to take their medicines, says Hagop M. Kantarjian, M.D., Baker Institute Scholar in Health Policy. HPR-Newsletter-March2014.pdf Print This Publication Share Facebook Twitter Email Linkedin Related Research Center for Health and Biosciences | Policy Brief Nonprofit Hospitals and Medical Debt in Indiana Read More Science and Technology Policy | Center for Health and Biosciences | Report Voting for Party, Not for Public Health Read More Election 2024: Policy Playbook | Center for Health and Biosciences | Policy Brief Boost Texas Health Outcomes Through Smart Spending Read More Back to top
Center for Health and Biosciences | Policy Brief Nonprofit Hospitals and Medical Debt in Indiana Read More
Science and Technology Policy | Center for Health and Biosciences | Report Voting for Party, Not for Public Health Read More
Election 2024: Policy Playbook | Center for Health and Biosciences | Policy Brief Boost Texas Health Outcomes Through Smart Spending Read More
